메인비쥬얼
컨텐츠
PR Video
-
NOTICE
- Huons Group Successfully Hosts Launch Symposium for Botulinum Toxin `Hutox` in China 2026/07/20
- Huons BioPharma Selected for Funding by the Korea Drug Development Fund to Advance Peptide Eye Drops for Dry Age-related Macular Degeneration. 2026/06/23
- Huons BioPharma Secures Approval in Kuwait for Botulinum Toxin 2026/05/08
- Huons BioPharma Appoints Jeonghee Lee as New CEO 2026/04/14
- Huons BioPharma Dispatches First Shipment of Botulinum Toxin to China 2026/03/16
- Huons BioPharma Secures NMPA Approval for Type A Botu-linum Toxin in China 2026/01/09
